Literature DB >> 21975287

Multiplex polymerase chain reaction pathogen detection in patients with suspected septicemia after trauma, emergency, and burn surgery.

Nam K Tran1, David H Wisner, Timothy E Albertson, Stuart Cohen, David Greenhalgh, Tina L Palmieri, Christopher Polage, Gerald J Kost.   

Abstract

BACKGROUND: The goal of this study is to determine the clinical value of multiplex polymerase chain reaction (PCR) study for enhancing pathogen detection in patients with suspected septicemia after trauma, emergency, and burn surgery. PCR-based pathogen detection quickly reveals occult bloodstream infections in these high-risk patients and may accelerate the initiation of targeted antimicrobial therapy.
METHODS: We conducted a prospective observational study comparing results for 30 trauma and emergency surgery patients to 20 burn patients. Whole-blood samples collected with routine blood cultures (BCs) were tested using a new multiplex, PCR-based, pathogen detection system. PCR results were compared to culture data.
RESULTS: PCR detected rapidly more pathogens than culture methods. Acute Physiology and Chronic Health Evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA), and Multiple Organ Dysfunction (MODS) scores were greater in PCR-positive versus PCR-negative trauma and emergency surgery patients (P ≤ .033). Negative PCR results (odds ratio, 0.194; 95% confidence interval, 0.045-0.840; P = .028) acted as an independent predictor of survival for the combined surgical patient population.
CONCLUSION: PCR detected the presence of pathogens more frequently than blood culture. These PCR results were reported faster than blood culture results. Severity scores were significantly greater in PCR-positive trauma and emergency surgery patients. The lack of pathogen DNA as determined by PCR served as a significant predictor of survival in the combined patient population. PCR testing independent of traditional prompts for culturing may have clinical value in burn patients. These results warrant further investigation through interventional trials. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21975287      PMCID: PMC3304499          DOI: 10.1016/j.surg.2011.07.030

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

1.  Early detection and identification of commonly encountered Candida species from simulated blood cultures by using a real-time PCR-based assay.

Authors:  Younes Maaroufi; Jean-Marc De Bruyne; Valérie Duchateau; Aspasia Georgala; Françoise Crokaert
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

Review 2.  Cell response to surgery.

Authors:  Niamh Ni Choileain; H Paul Redmond
Journal:  Arch Surg       Date:  2006-11

3.  Septicemia as a cause of death in burns: an autopsy study.

Authors:  B R Sharma; D Harish; Virendar Pal Singh; Sumedha Bangar
Journal:  Burns       Date:  2006-08       Impact factor: 2.744

4.  Meningococcal bacterial DNA load at presentation correlates with disease severity.

Authors:  S J Hackett; M Guiver; J Marsh; J A Sills; A P J Thomson; E B Kaczmarski; C A Hart
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

Review 5.  Immunomodulation following burn injury.

Authors:  J F Hansbrough; R L Zapata-Sirvent; V M Peterson
Journal:  Surg Clin North Am       Date:  1987-02       Impact factor: 2.741

6.  Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics.

Authors:  Diane Flayhart; Anita P Borek; Teresa Wakefield; James Dick; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

8.  American Burn Association consensus conference to define sepsis and infection in burns.

Authors:  David G Greenhalgh; Jeffrey R Saffle; James H Holmes; Richard L Gamelli; Tina L Palmieri; Jureta W Horton; Ronald G Tompkins; Daniel L Traber; David W Mozingo; Edwin A Deitch; Cleon W Goodwin; David N Herndon; James J Gallagher; Art P Sanford; James C Jeng; David H Ahrenholz; Alice N Neely; Michael S O'Mara; Steven E Wolf; Gary F Purdue; Warren L Garner; Charles J Yowler; Barbara A Latenser
Journal:  J Burn Care Res       Date:  2007 Nov-Dec       Impact factor: 1.845

9.  Risk factors for nosocomial bloodstream infections.

Authors:  Eleni Apostolopolou; Georgios Katsaris; Theophanis Katostaras
Journal:  Br J Nurs       Date:  2003 Jun 26-Jul 9

10.  Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials.

Authors:  Lutz E Lehmann; Bernd Herpichboehm; Gerald J Kost; Marin H Kollef; Frank Stüber
Journal:  Crit Care       Date:  2010-10-15       Impact factor: 9.097

View more
  10 in total

Review 1.  Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomes.

Authors:  K Z Vardakas; F I Anifantaki; K K Trigkidis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-02       Impact factor: 3.267

2.  Molecular diagnosis of sepsis: New aspects and recent developments.

Authors:  O Liesenfeld; L Lehman; K-P Hunfeld; G Kost
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

3.  The Immune Response to Skin Trauma Is Dependent on the Etiology of Injury in a Mouse Model of Burn and Excision.

Authors:  Samantha M Valvis; Jason Waithman; Fiona M Wood; Mark W Fear; Vanessa S Fear
Journal:  J Invest Dermatol       Date:  2015-05-07       Impact factor: 8.551

4.  Cutaneous Burn Injury Promotes Shifts in the Bacterial Microbiome in Autologous Donor Skin: Implications for Skin Grafting Outcomes.

Authors:  Jennifer K Plichta; Xiang Gao; Huaiying Lin; Qunfeng Dong; Evelyn Toh; David E Nelson; Richard L Gamelli; Elizabeth A Grice; Katherine A Radek
Journal:  Shock       Date:  2017-10       Impact factor: 3.454

5.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

6.  Point-of-Care Testing at the Disaster-Emergency-Critical Care Interface.

Authors:  Nam K Tran; Zachary Godwin; Jennifer Bockhold
Journal:  Point Care       Date:  2012-12-01

Review 7.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

8.  Burn Injury Leads to Increased Long-Term Susceptibility to Respiratory Infection in both Mouse Models and Population Studies.

Authors:  Vanessa S Fear; James H Boyd; Suzanne Rea; Fiona M Wood; Janine M Duke; Mark W Fear
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

9.  A retrospective cohort study to compare post-injury admissions for infectious diseases in burn patients, non-burn trauma patients and uninjured people.

Authors:  Janine M Duke; Sean M Randall; James H Boyd; Mark W Fear; Suzanne Rea; Fiona M Wood
Journal:  Burns Trauma       Date:  2018-06-12

Review 10.  Viral Infections in Burn Patients: A State-Of-The-Art Review.

Authors:  Jacek Baj; Izabela Korona-Głowniak; Grzegorz Buszewicz; Alicja Forma; Monika Sitarz; Grzegorz Teresiński
Journal:  Viruses       Date:  2020-11-17       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.